跳至主要内容
临床试验/NCT02714998
NCT02714998已完成不适用

The Impact of Salpingectomy and Single Dose Systemic Methotrexate Treatments on Ovarian Reserve in Ectopic Pregnancy

Ege University1 个研究点 分布在 1 个国家目标入组 131 人开始时间: 2013年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
131
试验地点
1
主要终点
Ovarian reserve assessment by measuring AMH level.

研究概览

简要总结

The investigators aimed to investigate the effects of salpingectomy and Methotrexate administration on ovarian reserve in ectopic pregnancy.

详细描述

In this study, the effects of unilateral laparoscopic salpingectomy and single dose of systemic Methotrexate administration on ovarian reserve in patients diagnosed with ectopic pregnancy were investigated.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • ectopic pregnancy diagnosis

排除标准

  • history of endometriosis, ovarian surgery, systemic chemotherapy, ART treatment.
  • patients treated with multiple doses of methotrexate or different surgical procedure (salpingostomy, milking)

研究组 & 干预措施

Methotrexate only

Active Comparator

Single dose of systemic Methotrexate administered to 55 patients.

干预措施: Methotrexate (Drug)

Salpingectomy only group

Active Comparator

Laparoscopic unilateral salpingectomy performed to 61 patients.

干预措施: salpingectomy (Procedure)

Salpingectomy following Methotrexate

Active Comparator

15 patients underwent laparoscopic unilateral salpingectomy following unsuccessful single dose of methotrexate administration.

干预措施: Methotrexate (Drug)

Salpingectomy following Methotrexate

Active Comparator

15 patients underwent laparoscopic unilateral salpingectomy following unsuccessful single dose of methotrexate administration.

干预措施: salpingectomy (Procedure)

结局指标

主要结局

Ovarian reserve assessment by measuring AMH level.

时间窗: 1-3 months

Ovarian reserve were assessed before and after treatment by measuring AMH levels.

次要结局

  • Number of participants with treatment related adverse effect on fertility.(2 years of follow up after treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Enes Taylan

Medical Doctor, Ob&Gyn Specialist

Ege University

研究点 (1)

Loading locations...

相似试验